Steady Expansion Forecast for Genomic And Proteomic Tool Market, Projected to Reach $51.19 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genomic And Proteomic Tool Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been a substantial expansion in the market size of genomic and proteomic tools in recent years. The market, which is at $29.63 billion in 2024, is expected to escalate to $33.14 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. Factors contributing to the growth during the historic phase include an increase in cancer and rare diseases, enlargement of academic central labs, augmentation in healthcare expenditure by affluent nations, normalization of clinical guidelines for molecular testing, and wider coverage of molecular diagnostics.

Genomic And Proteomic Tool Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, it is forecasted that the market size for genomic and proteomic tools will upward-trend rapidly, eventually reaching $51.20 billion in 2029 with an 11.5% compound annual growth rate (CAGR). This growth can be traced back to factors including an aging population and the corresponding increase in chronic illnesses, the incorporation of precision medicine into national health schemes, broader payer coverage for biomarker testing, a rise in clinical trials requiring molecular stratification, and the shift towards value-based care that incentivizes targeted therapies. The forecast period will also see key trends such as advancements in deoxyribonucleic acid long-read sequencing, improved throughput in single-cell ribonucleic acid sequencing, simultaneous detection of ribonucleic acid and proteins in place, absolute quantification through digital polymerase chain reaction, and the use of trapped ion mobility spectrometry in proteomic analysis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genomic-and-proteomic-tool-global-market-report

What Are the Drivers Transforming the Genomic And Proteomic Tool Market?
The genomic and proteomic tool market is set to grow rapidly due to heightened application of personalized medicine. This specialized approach to prevention, diagnosis, and treatment uses DNA, RNA, and protein biomarkers to create a unique molecular profile for each patient. The growth in the application of personalized medicine is facilitated by advancements in genomics, proteomics, and biomarker discovery, leading to targeted treatments based on specific genetic profiles. This accelerates the need for bespoke therapies, refined diagnostics, and precision healthcare services. These advances have also resulted in the creation of more precise diagnostics and targeted therapies tailored to the genetic makeup of a patient. Genomic and proteomic tools are integral in identifying genetic variations and protein biomarkers, thereby enabling healthcare professionals to refine treatments and enhance patient results. For instance, the Personalized Medicine Coalition, an American nonprofit body, received approval from the U.S. Food and Drug Administration (FDA) for 16 new personalized treatments for rare diseases in February 2024, a notable increase from just six approvals in 2022. Consequently, the genomic and proteomic tool market continues to be driven by the expanding use of personalized medicine.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28235&type=smp

What Long-Term Trends Will Define the Future of the Genomic And Proteomic Tool Market?
Leading companies within the genomic and proteomic tools market are prioritizing innovation via spatial multi-omics technologies. Such technologies allow the simultaneous in-situ detection of proteins and RNA in the same cell, facilitating the integration of multiple molecular data layers, preservation of tissue structure, and speeding up discovery. Spatial multi-omics allows for the evaluation of protein markers and gene expression in intact tissue with single-cell or subcellular resolution, giving more comprehensive biological insights than singular modality assays. For example, 10x Genomics, a biotechnology company based in the U.S, unveiled their Xenium Protein in August 2025 - a first in its class assay for single-cell RNA and protein analysis on the Xenium in-situ platform. This platform offers a fluid, single-instrument workflow that removes the need for cross-platform data integration, and it comes pre-loaded with validated, ready-to-use protein subpanels for ease of setup and quality control. These breakthroughs enable scientists to retain spatial context while broadening biomarker panels for uses such as target validation, patient categorisation, and mechanism-of-action investigations.

Which Segments in the Genomic And Proteomic Tool Market Offer the Most Profit Potential?
The genomic and proteomic tool market covered in this report is segmented as

1) By Product Type: Instruments, Consumables, Software, Services
By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography
3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research
5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers

Subsegments:
1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers
2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals
3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms
4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28235&type=smp

Which Firms Dominate the Genomic And Proteomic Tool Market by Market Share and Revenue in 2025?
Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, dic*kinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., Sophia Genetics, LC Sciences.

Which Regions Offer the Highest Growth Potential in the Genomic And Proteomic Tool Market?
North America was the largest region in the genomic and proteomic tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in genomic and proteomic tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28235

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.